dr. agarwal on the checkmate-214 trial for kidney cancer
Published 6 years ago • 120 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:02
dr. agarwal on next steps in kidney cancer
-
2:18
dr. agarwal on frontline treatment in kidney cancer
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
0:53
dr. agarwal on emerging immunotherapeutic combinations in kidney cancer
-
1:37
dr. amin on rationale for checkmate-214 trial in rcc
-
1:06
dr. mckay discusses the checkmate-214 trial in rcc
-
1:50
dr. agarwal on pfs2 data from the titan trial in mcspc
-
0:49
dr. agarwal on remaining questions with renal cell carcinoma
-
3:07
checkmate-214: nivolumab/ipilimumab for mrcc?
-
1:57
dr. agarwal discusses results of keynote-426 in mrcc
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
1:37
dr. agarwal on the talapro-2 trial in mcrpc
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:24
dr. motzer on the tivo-1 trial with tivozanib in advanced rcc
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
-
1:12
dr. agarwal on second-line therapy selection in metastatic rcc
-
1:21
dr. hammers on the long-term benefits of the checkmate-214 study in rcc